ArticleHemaSphere2024
On behalf of the SFGM-TC: Real-life use of third-party virus-specific T-cell transfer in immunocompromised transplanted patients.
Abstract read
In one paragraph
Article in HemaSphere, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Harnessing virus-specific T cells: expanding therapeutic strategies across diverse populations.Blood advances · 2025Review
- Virus-Specific T-Cell Therapy for Prophylaxis and Treatment of Cytomegalovirus Infections After Transplantation: a Scoping Review.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025Article
- Alloreactive-free CAR-VST therapy: a step forward in long-term tumor control in viral context.Frontiers in immunology · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
45 authors.
Esther Hazane LeroyerDepartment of Hematology Nancy University Hospital Vandoeuvre-les-Nancy France.ORCID 0009-0005-6084-7937
Nadine PetitpainRegional Centre of Pharmacovigilance Nancy University Hospital Vandoeuvre-les-Nancy France.
Stéphane MorissetStatistical Unit Pérouges France.
Bénédicte NevenAssistance Publique des Hôpitaux de Paris, Department of Pediatric Immuno-hematology Necker Children Hospital Paris France.
Martin CastelleAssistance Publique des Hôpitaux de Paris, Department of Pediatric Immuno-hematology Necker Children Hospital Paris France.
Sarah WinterAssistance Publique des Hôpitaux de Paris, Department of Pediatric Immuno-hematology Necker Children Hospital Paris France.
Laetitia SouchetAssistance Publique des Hôpitaux de Paris, Department of Hematology La Pitié-Salpêtrière Hospital Paris France.
Véronique MorelAssistance Publique des Hôpitaux de Paris, Department of Hematology La Pitié-Salpêtrière Hospital Paris France.
Marie Le CannAssistance Publique des Hôpitaux de Paris, Department of Hematology La Pitié-Salpêtrière Hospital Paris France.
Mony FahdDepartment of Pediatric Hematology and Immunology, Robert Debré Academic Hospital GHU APHP Nord Université Paris Cité Paris France.
Karima YacoubenDepartment of Pediatric Hematology and Immunology, Robert Debré Academic Hospital GHU APHP Nord Université Paris Cité Paris France.
Françoise MechinaudDepartment of Pediatric Hematology and Immunology, Robert Debré Academic Hospital GHU APHP Nord Université Paris Cité Paris France.
Marie Ouachée-ChardinInstitute of Pediatric Hematology and Oncology (IHOPe) Hospices Civils de Lyon and Claude Bernard University Lyon France.
Cécile RenardInstitute of Pediatric Hematology and Oncology (IHOPe) Hospices Civils de Lyon and Claude Bernard University Lyon France.
Hélène Labussière WalletInstitute of Pediatric Hematology and Oncology (IHOPe) Hospices Civils de Lyon and Claude Bernard University Lyon France.
Marie AngosoDepartment of Pediatric Hematology Oncology University Hospital of Bordeaux Bordeaux France.
Charlotte JubertDepartment of Pediatric Hematology Oncology University Hospital of Bordeaux Bordeaux France.
Patrice ChevallierDepartment of Hematology Nantes University Hospital Nantes France.
Alexandra LégerDepartment of Pediatric Hematology, Hôpital Mère-Enfant Nantes University Hospital Nantes France.
Fanny RiallandDepartment of Pediatric Hematology, Hôpital Mère-Enfant Nantes University Hospital Nantes France.
Nathalie DhedinAssistance Publique des Hôpitaux de Paris, Department of Hematology Saint-Louis Hospital Paris France.
Christine RobinAssistance Publique des Hôpitaux de Paris, Department of Hematology Henri Mondor Hospital and Université Créteil France.
Sébastien MauryAssistance Publique des Hôpitaux de Paris, Department of Hematology Henri Mondor Hospital and Université Créteil France.
Florence BeckerichAssistance Publique des Hôpitaux de Paris, Department of Hematology Henri Mondor Hospital and Université Créteil France.
David BeauvaisDepartment of Hematology, Allogeneic Stem Cell Transplantation Unit Lille University Hospital Lille France.
Thomas CluzeauDepartment of Hematology, Université Cote d'Azur Nice University Hospital Nice France.
Michaël LoschiDepartment of Hematology, Université Cote d'Azur Nice University Hospital Nice France.
Alina FernsterHôpital Universitaire des Enfants de la Reine Fabiola, Department of Pediatric Hematology Brussels University Hospital Brussels Belgium.
Marcelo De Carvalho BittencourtCytometry Platform Nancy University Hospital Vandoeuvre-les-Nancy France.
Maxime CravatCytometry Platform Nancy University Hospital Vandoeuvre-les-Nancy France.
Karin BilgerINCANS Department of Hematology Strasbourg France.
Laurence ClémentDepartment of Hematology Bordeaux University Hospital Bordeaux France.
Véronique DecotCell Therapy Unit Nancy University Hospital Vandoeuvre-les-Nancy France.
Mélanie GauthierCell Therapy Unit Nancy University Hospital Vandoeuvre-les-Nancy France.
Anne LegendreEFS La Plaine St-Denis France.
Jérôme LargheroAssistance Publique des Hôpitaux de Paris, Cell Therapy Unit, INSERM CICBT 501 Saint-Louis Hospital Paris France.
Amani OuedraniAssistance Publique des Hôpitaux de Paris, Department of Immunology and Histocompatibily Saint-Louis Hospital Paris France.
Guillaume Martin-BlondelDepartment of Infectious and Tropical Diseases, and Toulouse Institute for Infectious and Inflammatory Diseases, INSERM UMR1291-CNRS UMR5051-Université Toulouse III Toulouse University Hospital Toulouse France.
Cécile PochonDepartment of Pediatric Hematology Nancy University Hospital Vandoeuvre-les-Nancy France.
Loïc ReppelCell Therapy Unit Nancy University Hospital Vandoeuvre-les-Nancy France.
Hélène RouardEFS La Plaine St Denis St Denis France.
Stéphanie Nguyen-QuocAssistance Publique des Hôpitaux de Paris, Department of Hematology La Pitié-Salpêtrière Hospital Paris France.
Jean-Hugues DalleDepartment of Pediatric Hematology and Immunology, Robert Debré Academic Hospital GHU APHP Nord Université Paris Cité Paris France.
Maud D'AveniDepartment of Hematology Nancy University Hospital Vandoeuvre-les-Nancy France.
Danièle BensoussanCell Therapy Unit Nancy University Hospital Vandoeuvre-les-Nancy France.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.